Choline counteracts pregnancy undernutrition-associated colitis in sheep by restoring microbiota driven bile acid metabolism Authors: Weibin Wu, Peng Jiao, Yamei Gu, Huizhen Lu, Caiyun Fan, Zheng Sun, Lizhuang Hao, Shengyong Mao, Jianbo Cheng, Yanfeng Xue Published: 2026 ABSTRACT AbstractHigh-fertility sheep experience undernutrition during late gestation, which induces body metabolic disruption and intestinal inflammation. Crucially, the gut microbiota-bile acid axis is a promising intestinal inflammation target, but how choline modulates this axis in livestock enteritis is unknown. This study investigated choline’s protective mechanisms against undernutrition-induced intestinal inflammation in sheep, focusing on gut microbiota and bile acid regulation. Choline consistently alleviates colitis severity, restores epithelial barrier integrity, and suppresses intestinal inflammation. These protective effects are accompanied by pronounced remodeling of the colonic microbial ecosystem, characterized by the enrichment of Clostridiales bacterium to elevate bile salt hydrolase activity and regulate bile acid homeostasis. Concomitantly, choline reshapes colonic bile acid profiles, normalizing total bile acid levels and selectively restoring DCA abundances. Mechanistically, the anti-inflammatory effects of DCA depend on Nur77 activation and subsequent suppression of NF-κB signaling across in vivo and in vitro systems. These findings provide preliminary evidence for a putative choline-microbiota-bile acid-immune signaling axis that confers protection against undernutrition-associated colitis and support choline intervention as a pregnancy-compatible nutritional strategy for intestinal inflammatory disorders in animal. Subject terms: Gastroenterology, Microbiology Introduction Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease1,2. Livestock enteritis annually causes at least $6 billion economic loss in the world with costs escalating yearly, so exploring effective nutritional intervention strategy’s is critically important and urgent3–6. Hu-sheep, a renowned Chinese sheep originating from the Tai-Lake region, are characterized by high fertility rates, year-round estrus cycles, and rapid growth performance. Hu-sheep’s exceptional reproductive capacity predisposes them to undernutrition during late gestation, which disrupts metabolic homeostasis and induces intestinal inflammatory responses7–10. Undernutrition disrupts systemic metabolic homeostasis, impairs intestinal barrier function, and predisposes the gut to inflammatory injury, while chronic intestinal inflammation further aggravates malnutrition through malabsorption and metabolic dysregulation, establishing a deleterious bidirectional relationship9,11. However, therapeutic options for managing IBD during pregnancy are limited, as many pharmacological interventions carry potential risks to fetal development. Consequently, there is a pressing need to identify safe and pregnancy-compatible strategies that can mitigate intestinal inflammation under conditions of prenatal nutritional deficiency. Emerging evidence indicates that microbiota-derived bile acids play pivotal roles in maintaining intestinal immune homeostasis in livestock under metabolic stress conditions12–15. Typically, these specific bile acids act as signaling molecules that engage host immune receptors to suppress excessive inflammatory responses. As a potent modulator of gut microbiota, choline may affect the enterohepatic circulation of bile acids and exert anti-inflammatory function16,17. Against this backdrop, choline emerges as a uniquely promising intervention candidate for intestinal inflammation, given its established status as an essential nutrient recommended for pregnant women18. Recent studies have reported that choline and its metabolites may attenuate experimental colitis, suggesting a potential therapeutic role in IBD19,20. However, unlike typical chemically induced models, pregnancy-associated undernutrition presents a complex dual-challenge of severe systemic energy deficit and localized immune dysfunction. While our previous research demonstrated that choline can ameliorate metabolic disturbances in the blood, urine, and rumen fluid of undernourished pregnant ewes21,22, its specific efficacy against intestinal inflammation in this vulnerable context, alongside the precise microbiota-bile acid mechanisms, remain largely unexplored. Therefore, we hypothesized that maternal choline supplementation protects against pregnancy-associated undernutrition-induced colitis by reshaping the gut microbiota and restoring specific secondary bile acid-mediated immune signaling. To test this hypothesis, we utilized a late-gestation sheep undernutrition model and a comprehensively restricted pregnant mouse model. Here, Choline consistently alleviates colitis, restores epithelial barrier integrity, and suppresses intestinal inflammation. At the mechanistic level, choline reshapes the colonic microbiota, enhances bile salt hydrolase (BSH) activity, and remodels bile acid composition, leading to the restoration of deoxycholic acid (DCA) abundances. We further identify Nur77 as a DCA-responsive downstream regulator that links choline-derived DCA signaling to the suppression of NF-κB-mediated inflammatory responses. In summary, our research establishes choline as a viable and pregnancy-compatible nutritional intervention, potentially exerting a protective effect against undernutrition-associated colitis via the coordinated modulation of the gut microbiota-bile acid-immune signaling axis. Results Choline alleviates undernutrition-induced colitis in pregnant sheep To examine the effects of undernutrition and choline supplementation on colonic epithelial barrier integrity during pregnancy, pregnant sheep were subjected to late-gestation undernutrition with or without rumen-protected choline chloride (RPC) supplementation. The results showed that undernutrition during late gestation induced weight loss and shortened colonic length while choline supplementation effectively reversed the phenotype (Fig. 1a, b). Hematoxylin-eosin (HE) staining sections showed choline supplementation could repair the enlarged intercellular spaces, disorganized epithelial architecture, and increased infiltration of inflammatory cells in colonic epithelium caused by undernutrition (Fig. 1c, d). Undernutrition decreased the levels of tight junction proteins Claudin-1 and ZO-1, while choline supplementation reversed the levels of these two proteins in immunofluorescence analysis, showing choline’s protective effect in epithelial barrier function (Fig. 1e–g). Periodic acid-schiff (PAS) staining sections demonstrated that choline supplementation could restore the number of goblet cells reduced by undernutrition (Fig. 1h, i). Undernutrition increased IL-1β, IL-6, and TNF-α at both the transcript and protein levels in colonic tissue, whereas choline supplementation suppressed these pro inflammatory signals (Fig. 1j–m). Collectively, choline supplementation effectively alleviates undernutrition-induced colitis in pregnant sheep. Choline alleviates undernutrition-induced colonic damage and inflammation in pregnant sheep. Two independent cohorts of sheep at 108 days of gestation (n = 8) were subjected to either severe undernutrition (30% of ad libitum intake, SUN) or undernutrition (50% of ad libitum intake, UN) or RPC supplementation (50% of ad libitum intake + RPC, RPC). a, b Body weight and colonic length. c Colonic HE staining sections. d Histological score. e Colonic immunofluorescence staining sections. f, g Fluorescence intensity and gene expression of tight junction proteins in the colon. h Colonic PAS staining sections. i The number of goblet cells in colonic epithelium under 40x field views. j–m Colonic pro-inflammatory cytokine concentrations and gene expression. Data were presented as mean ± SEM. Statistical analysis was performed using a two-tailed Student’s t test or a two-tailed Wilcoxon rank-sum test. Choline alleviates colitis in CR- and DSS-induced mouse models To assess the effects of choline on colitis under the condition of pregnancy-associated undernutrition, a caloric restriction (CR) regimen mimicking gestational undernutrition was established in mice and choline was administered during disease induction (Supplementary Fig. 1a). In the CR model, choline significantly attenuated colitis severity, as indicated by reduced body weight loss and preserved colon length (Supplementary Fig. 1b–d). Histological assessment further showed markedly decreased inflammatory cell infiltration and crypt damage, resulting in lower pathology scores (Supplementary Fig. 1e, f). Moreover, barrier restoration and inflammation reduction was observed, including increased Claudin-1 and ZO-1 levels, elevated the number of goblet cell, and decreased the levels of pro-inflammatory cytokines (Supplementary Fig. 1g–m). To assess the reproducibility of these protective effects in a conventional model of colitis, we subsequently employed the DSS-induced colitis paradigm (Supplementary Fig. 2a). Consistent with the CR findings, choline mitigated DSS-associated weight loss, lower disease activity index (DAI) scores, and colon shortening and alleviated intestinal tissue injury (Supplementary Fig. 2b–g). Consistently, choline restored epithelial barrier features, including increased Claudin-1 and ZO-1 levels and the number of goblet cell, and reduced colonic levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) (Supplementary Fig. 2h–n). Together, choline exerts consistent protective effects against colitis across both pregnancy-associated CR and DSS-models. Choline-modulated colonic microbiota mediates protection against CR-induced colitis To assess whether microbiota modulation contributes to the protective effects of choline, colonic microbiota from ewes in the RPC group were transplanted into pregnant mice with CR-induced colitis via oral gavage using FMT method (Supplementary Fig. 3a). As expected, FMT significantly alleviated body weight loss induced by CR and also restored the shortened colon length (Supplementary Fig. 3b–d). Histopathological analysis further demonstrated that FMT markedly ameliorated CR-induced pathological alterations, including inflammatory cell infiltration and crypt damage, leading to a significant reduction in histological score (Supplementary Fig. 3e, f). Consistently, PAS staining sections showed that FMT significantly increased the number of goblet cells that had been reduced by CR (Supplementary Fig. 3g, h). In parallel, FMT markedly suppressed the CR-induced upregulation of pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, at both the transcriptional and protein levels (Supplementary Fig. 3i, j). Moreover, FMT effectively restored the CR-induced downregulation of the tight junction proteins Claudin-1 and ZO-1 at both the protein and mRNA levels (Supplementary Fig. 3k–m). Collectively, FMT derived from choline-supplemented ewes effectively alleviates pregnancy-associated colitis, supporting the notion that choline may exert its anti-inflammatory effects through the modulation of intestinal microbiota. Choline improves colonic microbiota dysbiosis induced by undernutrition To characterize the impact of undernutrition and choline on colonic microbial composition and function, metagenomic analysis was performed in the pregnant sheep model. Choline lowered colonic pH (Fig. 2a), which could be attributed to the increased concentrations of volatile fatty acids (Supplementary Fig. 4a). Choline intervention restored the undernutrition-changed molar ratios of VFAs (Fig. 2b) and increased the concentration of microbial protein (MCP) (Fig. 2c), suggesting that choline might exert its effect by affecting the community of intestinal microorganisms. The partial least squares discriminant analysis (PLS-DA) in metagenomics showed that both undernutrition and choline intervention could alter the colonic microbiota composition (Fig. 2d). The α diversity results showed that undernutrition tended to decrease ACE and Chao indices, while choline intervention increased the ACE index and decreased the Simpson index (Fig. 2e). Interestingly, undernutrition decreased the carbohydrate metabolism function of colonic microbes (Supplementary Fig. 4b), while choline intervention enhanced that (Fig. 2f). At the phylum level, undernutrition increased the relative abundance of Bacillota and Actinomycetota and decreased Bacteroidota, Spirochaetota, and Euryarchaeota abundances; while choline intervention increased Bacillota, Fibrobacterota, and Spirochaetota abundances, and decreased Pseudomonadota, Uroviricota, and Thermodesulfobacteriota abundances (Fig. 2g). At the genus level, undernutrition decreased Bacteroides, Phocaeicola, Treponema, and Methanocorpusculum abundances; while choline intervention increased Clostridium and Ruminococcus abundances, and decreased Phocaeicola, Escherichia, Providencia, and Prevotella abundances (Fig. 2h). Collectively, undernutrition disrupts colonic microbial diversity, composition, and metabolic potential, while choline supplementation partially restores microbiota homeostasis. Choline intervention improves colonic microbiota dysbiosis caused by undernutrition. a–c Colonic content pH, VFA molar ratios, and MCP concentration (n = 8). d, e Genus-level PLS-DA plot and α-diversity indices of colonic microbiota (n = 6). f The metabolic pathway associated with carbohydrate and amino acid (n = 6). Red font indicates significantly upregulated enzyme genes while blue font indicates significantly downregulated enzyme genes. g The relative abundance of colonic microbiota at phylum level (n = 6). Phyla with >1% relative abundance at least in one group. Red arrow indicates a significant increase while blue arrow indicates a significant decrease in the relative abundance of phylum. h The 10 genera with the highest relative abundance in the colonic microbiota (n = 6). Data were presented as mean ± SEM. Statistical analysis of data was performed using a two-tailed Student’s t test or a two-tailed Wilcoxon rank-sum test. *p < 0.05. Choline restores colonic BSH activity disrupted by undernutrition KEGG and cluster of orthologous groups of proteins (COG) enrichment in metagenome analysis showed that undernutrition reduced the abundance of BSH, while choline intervention tended to increase the abundance of BSH (Supplementary Fig. 4c). Subsequently, BSH activity detection showed that undernutrition reduced the actual activity of BSH, while choline intervention increased BSH activity (Fig. 3a). Next, we analyzed the genera with BSH gene and found that Bacteroides, Phocaeicola, and Treponema, as well as Clostridium and Ruminococcus, which were among the top 10 genera under undernutrition and choline intervention conditions, respectively, had BSH gene (Fig. 3b). Interestingly, Bacteroides, Phocaeicola, and Treponema abundances were decreased upon undernutrition, while Clostridium and Ruminococcus abundances were increased upon choline intervention (Fig. 2h). The VIP scores and linear discriminant analysis (LDA) scores of colonic bacteria also indicated that these five genera were important for the discrimination of total microbial profiles upon undernutrition or choline intervention (Supplementary Fig. 4d, e). Co-occurrence network analysis of colonic bacteria revealed that under undernutrition and choline intervention, Bacteroides and Clostridium showed increased variability, respectively (Fig. 3c). Species-level analysis showed that the abundance of colonic C. bacterium slightly decreased upon undernutrition but significantly increased after choline intervention (Fig. 3d). VIP scores revealed that C. bacterium was the primary microbiota driving group separation (Supplementary Fig. 4f). Notably, the relative abundance of C. bacterium was positively correlated with BSH activity (Fig. 3e). Collectively, undernutrition disrupts colonic BSH-related microbial function and enzymatic activity, while choline supplementation restores BSH activity in association with specific microbial taxa. Choline improve BSH activity by increasing C. bacterium abundance. a BSH activity in sheep colonic contents (n = 8). b Genera containing BSH gene in colonic microbiota are ranked according to the percentages of their BSH gene numbers (n = 6), in which genera whose relative abundances are in top 10 and show significant changes between the compared groups are highlighted in color. Red color indicates significantly increased genus while blue color indicates significantly decreased genus. c Network analysis of the co-occurrence of colonic microbiota based on core genera (top 50 abundant genera) (n = 6). d The 5 species with the highest relative abundance in the colonic microbiota (n = 6). e Correlation between the relative abundance of C. bacterium and BSH activity in sheep colonic contents (n = 6). Data were presented as mean ± SEM. Statistical analysis of data was performed using a two-tailed Student’s t test or a two-tailed Wilcoxon rank-sum test. *p < 0.05. C. bacterium increases BSH activity and attenuates CR-induced colitis The addition of choline directly promotes the proliferation of C. bacterium (12–72 h) and elevates the BSH activity (Fig. 4a, b and Supplementary Fig. 5a–c). To assess the function of C. bacterium colonization in vivo, mice subjected to CR-induced colitis were orally administered C. bacterium (Fig. 4c). Compared with CR, mice receiving C. bacterium displayed significantly reduced body weight loss and preserved colon length (Fig. 4d–f). C. bacterium colonization increased colonic BSH activity in relative to CR-treated mice (Fig. 4g) and improved pathological features, showing lowered inflammatory cell infiltration, crypt damage, and pathological scores (Fig. 4h, i). In addition, C. bacterium colonization preserved intestinal barrier integrity by preventing the loss of tight junction proteins (Claudin-1 and ZO-1) and the number of goblet cell (Fig. 4j–n). It further reduced the heightened pro-inflammatory cytokine levels associated with CR (Fig. 4o, p). Collectively, C. bacterium colonization increased colonic BSH activity and reduced the severity of CR-induced colitis in pregnant mouse model. Characterization of C. bacterium-mediated BSH activity and colitis phenotypes. a In vitro growth curves of C. bacterium with or without choline supplementation (n = 3). b BSH activity of C. bacterium at OD 600 nm = 1 following choline supplementation (n = 8). c Female BALB/c mice were maintained under SPF conditions. A pregnancy-associated CR model was established using a 50% CR regimen (n = 8). Mice in the CB were given 200 μL/d C. bacterium (1 × 108 CFU/200 μL) by oral gavage. d–f Body weight, colon photographs, and colon length of mice. g BSH activity of colonic content in mice. h, i Colonic HE staining sections and histological score. j Colonic immunofluorescence staining sections. k, l Fluorescence intensity and gene expression of tight junction proteins in the colon. m Colonic PAS staining sections. n The number of goblet cells in 40x field views in the colon. o, p Colonic pro-inflammatory cytokine concentrations and gene expression. Data were presented as mean ± SEM. Statistical analysis was performed using one-way ANOVA or non-parametric Kruskal-Wallis test. *p < 0.05. Choline reshapes colonic bile acid composition disrupted by undernutrition To identify the key microbial metabolites involved in choline-alleviated colitis, untargeted metabolomic was used to investigate the metabolic profiling changes of colonic digest in undernourished sheep model. The principal component analysis (PCA) plot of total metabolites revealed a distinct separation in the overall metabolic profiles between the UN and RPC groups (Fig. 5a). Among the differential metabolites, several bile acids including norcholic acid (NCA), taurochenodeoxycholic acid (TCDCA), chenodeoxycholic acid (CDCA), and glycoursodeoxycholic acid (GUDCA) were significantly decreased upon choline supplementation (Fig. 5b and Supplementary Table 1). KEGG pathways analysis of differential metabolites showed pyrimidine metabolism, steroid hormone biosynthesis, purine metabolism, linoleic acid metabolism, and galactose metabolism were significantly enriched (Fig. 5c). Notably, steroid hormone biosynthesis and linoleic acid metabolism pathways were closely related to bile acid metabolism. Subsequently, we further measured 65 kinds of key bile acids in the colon, using targeted bile acids detection method. Bile acid profiling analysis revealed that undernutrition markedly disrupted bile acids composition and increased total bile acid levels in the colon, whereas choline significantly restored those (Fig. 5d, e). Comprehensive profiling indicated that the restorative effect of choline was highly specific and left the majority of bile acid species unaffected (Supplementary Tables 2 and 3). Undernutrition decreased the abundance of secondary bile acids deoxycholic acid (DCA), while increased the levels of atypical bile acids such as isolithocholic acid (ILCA) and isoallolithocholic acid (IALCA). In contrast, choline supplementation increased the abundance of DCA and its derivatives 3β-DCA and 3-oxo-DCA (Fig. 5f, g and Supplementary Table 3). Notably, DCA represented the most abundant bile acid species across all experimental groups. Correlation analysis further demonstrated that colonic DCA abundance was negatively associated with histological inflammation scores and positively correlated with BSH activity (Fig. 5h, i). Collectively, undernutrition disrupts colonic bile acid composition and elevates total bile acid levels, whereas choline supplementation restores bile acid profiles, particularly DCA abundant. Changes in colonic bile acid profiles associated with undernutrition and choline intervention. a PCA plot of total metabolites in colonic contents from ewes (n = 6). b Pie chart of differential metabolite proportions in colonic contents (n = 6). c KEGG enrichment plot of differential metabolites in colonic contents (n = 6). d PLS-DA plot of total bile acids in the colon (n = 5). e Total bile acid concentrations in colon (n = 5). f Relative abundances of the top 10 bile acids in colon contents (n = 5). g The relative abundances of DCA in the colon (n = 5). h, i Correlation analyses of the relative abundance of DCA with colon histology score and BSH activity (n = 5). Data were presented as mean ± SEM. Statistical analysis of data was performed using a two-tailed Student’s t test or a two-tailed Wilcoxon rank-sum test. DCA attenuates CR-induced colitis in pregnant mouse model To examine the effects of DCA intervention on colitis severity, pregnant mice subjected to CR-induced colitis were administered with DCA by enema at the concentration comparable to physiological level observed in mice (Fig. 6a). Compared with CR group, DCA-treated mice exhibited significantly reduced body weight loss and preserved colon length (Fig. 6b–d). Histological examination further revealed that DCA supplementation markedly alleviated inflammatory cell infiltration and crypt damage, resulting in lower pathology scores (Fig. 6e, f). Consistent with these findings, DCA treatment restored the levels of tight junction proteins Claudin-1 and ZO-1 and increased the number of goblet cells (Fig. 6g–k). In parallel, colonic levels of pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, were significantly reduced by DCA intervention (Fig. 6l, m). Collectively, physiological level of DCA intervention attenuates CR-induced colitis in pregnant mouse model. DCA alleviates CR-induced colitis in a pregnant mouse model. a Female BALB/c mice were maintained under SPF conditions. A pregnancy-associated CR model was established using a 50% CR regimen (n = 8). Mice in the DCA were administered with 100 μL/d DCA at a physiological dose (20 mg/kg) by enema. b–d Body weight, colon photographs, and colon length. e, f Colonic HE staining sections and histological score. g Colonic immunofluorescence staining sections. h, i Fluorescence intensity and gene expression of tight junction proteins in the colon. j Colonic PAS staining sections. k The number of goblet cells in 40x field views. l, m Colonic pro-inflammatory cytokine concentrations and gene expression. Data were presented as mean ± SEM. Statistical analysis was performed using one-way ANOVA or non-parametric Kruskal-Wallis test. DCA attenuates colitis via Nur77-NF-κB signaling axis Transcriptomic profiling of colonic tissues from pregnant sheep subjected to late-gestation undernutrition and choline supplementation revealed distinct gene expression patterns between groups, as demonstrated by PLS-DA (Fig. 7a). Nur77 was one of the most strongly upregulated genes upon choline supplementation, and GSEA showed the significant suppression of NF-κB signaling pathway (Fig. 7b, c). Analysis of publicly available genome-wide association study (GWAS) data from the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) found that Nur77 is associated with disease susceptibility in IBD23. At the protein level, undernutrition markedly reduced colonic Nur77 expression and increased the phosphorylation level of p65, whereas choline supplementation restored Nur77 expression and suppressed p65 phosphorylation (Fig. 7d, e). To further examine the relationship between DCA and Nur77-NF-κB signaling, Caco-2 cells were treated with graded concentrations of DCA in the presence of TNF-α (Fig. 7f). DCA exerted a concentration-dependent effect on cell viability and pro-inflammatory cytokines levels, with 25 μM identified as the optimal concentration for antiinflammation (Fig. 7g–i). At this concentration, DCA reversed TNF-α-induced Nur77 protein expression downregulation and decreased p65 phosphorylation (Fig. 7j, k). Notably, oleanolic acid (OA) inhibition of Nur77 completely eliminated DCA’s regulating effects on Nur77 protein expression and p65 phosphorylation (Fig. 7l, m). Consistently, OA treatment also abolished the DCA-mediated suppression of pro-inflammatory cytokine production, as evidenced by restored IL-1β and IL-6 levels in the culture supernatant (Fig. 7n). To systematically integrate these findings across the cohort, structural equation model confirmed a sequential positive cascade (Supplementary Fig. 6). Choline supplementation directly drives the elevation of C. bacterium and BSH activity, which subsequently increases colonic DCA abundance to upregulate the host Nur77. Collectively, these findings suggest that choline may alleviate pregnancy-associated colitis by modulating the C. bacterium-DCA-Nur77-NF-κB signaling axis. Regulation of Nur77-NF-κB signaling by DCA. a PLS-DA plot of the transcriptome from sheep colon epithelium (n = 5). b Volcano plot of the transcriptome from sheep colon epithelium (n = 5). c GSEA plot of the NF-κB signaling pathway in the transcriptome from sheep colon epithelium (n = 5). d, e Protein expression levels of Nur77 and p65 in sheep colon epithelium (n = 3). f After 48 h of culture, Caco-2 cells were co-treated with DCA at varying concentrations (10, 25, 50, 100, and 200 μM) and TNF-α (10 ng/mL) for 12 h. g Cell viability of Caco-2 cells treated with different concentrations of DCA (n = 8). h, i The concentrations of IL-1β and IL-6 in the supernatant of Caco-2 cells (n = 8). j, k Protein expression levels of Nur77 and p65 in Caco-2 cells following 25 μM DCA treatment (n = 3). l, m Protein expression levels of Nur77 and p65 in Caco-2 cells following OA inhibitor intervention (n = 3). n Concentrations of IL-1β and IL-6 in the supernatant of Caco-2 cells following OA inhibitor intervention (n = 8). Data were presented as mean ± SEM. Statistical analysis of data was performed using a two-tailed Student’s t test or a two-tailed Wilcoxon rank-sum test (group number = 2). One-way ANOVA or the non-parametric Kruskal-Wallis test was used for statistical analysis of data (group number >2). Discussion A complex interplay exists between late-gestation undernutrition and IBD; however, the pathogenic mechanisms by which undernutrition predisposes to IBD remain poorly defined, and effective nutritional intervention strategies are largely lacking9,24,25. In this study, we demonstrate that choline supplementation provides robust protection against pregnancy-associated undernutrition related colitis. Choline improves intestinal barrier function and dampens inflammatory responses in parallel with remodeling of the colonic microbial ecosystem, characterized by the enrichment of BSH competent C. bacterium and the restoration of bile acid transforming capacity. This microbial reprogramming reshapes the colonic bile acid pool, prominently restoring physiological levels of DCA, which suppresses inflammation via the activation of Nur77 and the inhibition of NF-κB signaling. Together, our findings position choline as a pregnancy-compatible nutritional intervention that links microbial bile acid metabolism to host inflammatory control in the setting of nutritional deficiency. The intestinal epithelium constitutes a critical interface between nutrient absorption and immune surveillance, and disruption of epithelial barrier integrity is a central event in the initiation and perpetuation of intestinal inflammation26–28. Undernutrition represents a systemic metabolic stress that compromises epithelial renewal, tight junction organization, and mucosal defense, thereby lowering the threshold for inflammatory injury29,30. Previous studies have reported impaired intestinal barrier function under conditions of caloric or protein restriction, often accompanied by increased intestinal permeability and inflammatory activation9,31. Our findings extend this concept to late-gestation undernutrition and demonstrate that nutritional deficiency during pregnancy markedly exacerbates colonic barrier disruption and inflammatory responses. Importantly, therapeutic management of intestinal inflammation during pregnancy remains challenging, as many anti-inflammatory and immunosuppressive agents carry potential risks to fetal development and are therefore used with caution or avoided altogether32. In this context, nutritional interventions that are both effective and pregnancy-compatible are particularly attractive. Choline is an essential nutrient routinely recommended during pregnancy to support fetal development, with a well-established safety profile33. Most existing studies have focused on the detrimental effects of choline deficiency on intestinal inflammation, whereas direct evidence supporting a beneficial role of choline supplementation in colitis remains scarce34–36. Our study fills this gap by demonstrating that choline supplementation effectively mitigates barrier dysfunction and colonic inflammation upon gestational nutritional deficiency. Emerging evidence has positioned the gut microbiota-bile acid axis as a central regulator of intestinal immune homeostasis. Alterations in bile acid composition have been consistently reported in inflammatory bowel disease, reflecting both microbial dysbiosis and impaired metabolic transformation of primary bile acids37–40. In this context, BSH activity represents a critical metabolic checkpoint linking microbial composition to bile acid functionality41. Reduced BSH activity and impaired secondary bile acid production has been reported in patients with IBD and in experimental models of colitis42–44. Our data indicate that undernutrition disrupts this microbial metabolic capacity, whereas choline supplementation restores BSH activity through enrichment of BSH-competent C. bacterium. This finding is consistent with previous reports that dietary components can selectively shape bile acid-transforming microbial populations45,46. Notably, multiple members of the Clostridiales have been identified as contributors to BSH activity in the gut47,48. Primary bile acids undergo transformation into secondary bile acids via gut microbiota-derived BSH38,49. Secondary bile acids play critical roles in maintaining intestinal immune homeostasis50. Gut microbiota-derived DCA not only reduces the inflammatory response by inhibiting TNF-α production in macrophages through the TGR5-cAMP-PKA pathway, but also enhances the anti-colon cancer efficacy in the FOLFOX regimen via Ugt1a6b-mediated enterohepatic circulation37,51. LCA, promoted by Odoribacter splanchnicus, alleviates colonic inflammation via inhibiting the NLRP3-GSDMD signaling pathway to suppress neutrophil extracellular traps formation52. Together, these observations suggest that choline acts upstream of bile acid signaling by reprogramming microbial metabolic function rather than merely altering bile acid levels. Beyond microbial and metabolic remodeling, our study identifies a defined molecular pathway linking bile acid signaling to the suppression of intestinal inflammation. The restoration of DCA abundance is accompanied by the activation of nuclear receptor Nur77 and the inhibition of NF-κB signaling in systems in vivo and in vitro. Nur77 has been previously implicated as a negative regulator of inflammatory signaling and intestinal immune responses23,53,54, yet its connection to bile acid-mediated signaling in the context of undernutrition-associated colitis has not been established. Our findings extend this concept by positioning Nur77 as a DCA responsive mediator that translates microbial-derived metabolic cues into dampened inflammatory signaling. Importantly, pharmacological inhibition of Nur77 abolishes the anti-inflammatory effects of DCA, providing direct evidence that Nur77 is required for DCA-dependent suppression of NF-κB activation. This Nur77-centered signaling axis offers a mechanistic explanation for how restoration of bile acid homeostasis downstream of microbial remodeling can exert anti-inflammatory effects in the intestine. While our study delineates a choline-microbiota-bile acid-Nur77 signaling axis that protects against undernutrition-associated colitis, several limitations should be acknowledged. First, our mechanistic analyses primarily focused on the Nur77-NF-κB pathway as a downstream effector of deoxycholic acid signaling; however, bile acids are known to engage multiple host receptors and signaling pathways, which may also contribute to the observed anti-inflammatory effects and warrant further investigation. Secondly, the inherent variability of large animal studies and the relatively short-term nature of our intervention models limit the extrapolation of our findings. Because our models were specifically designed to address the acute metabolic crisis during late gestation, the current data cannot definitively reflect the long-term effects of choline. Consequently, future longitudinal cohort studies utilizing greater sample sizes and multiple independent batches, alongside postpartum tracking across subsequent reproductive cycles, are required to comprehensively evaluate the long-term efficacy and sustainability of this nutritional intervention. In summary, choline is identified as a nutritional modulator capable of restoring microbial bile acid transformation and associating with the DCA-Nur77-NF-κB signaling pathway, our study highlights a potential mechanistic link between dietary nutrients and intestinal immune homeostasis under conditions of metabolic vulnerability. Our findings suggest a potential framework for mitigating intestinal inflammation in livestock under conditions of late-gestation undernutrition. Methods Ethics statement All experimental procedures followed the guidelines of the Animal Welfare Committee, and the experimental protocols were approved by the Animal Experimentation and Use Committee of Anhui Agricultural University (AHAUXMSQ2024053). Sheep Undernutrition model: 16 purebred Hu-sheep at day 108 of gestation, characterized by comparable body weights, age (2-year-old), parity (2–3 parity), and litter size (carrying 2–3 fetuses, verified by ultrasound), were utilized in this experiment. All animals were offered feed ad libitum for 7 days to record individual intake. Ewes were then randomly assigned to a control group receiving 100% of the ad libitum intake or a severe undernutrition group receiving 30% of the ad libitum intake for 15 days. Jugular blood was collected before the morning meal. Choline intervention model: Another cohort of 16 purebred Hu-sheep at gestational day 108 with comparable body weights was fed ad libitum for 7 days to quantify baseline intake. Animals were then randomly assigned to an undernutrition group receiving 50% of the ad libitum intake or to the same restricted intake supplemented with rumen protected choline (RPC; 15 g/d, 20% choline; MENON, Shanghai, China) for 9 days. The daily dose of RPC was strictly determined based on our group previous research in Hu-sheep during late gestation21,22. Specifically, the RPC was uniformly mixed into the feed to ensure complete and consistent intake by the ewes. Blood samples was collected from the jugular vein of Hu-sheep before morning feeding. Undernutrition sheep models were successfully established in the SUN and UN groups at the end of experiments with their blood β-hydroxybutyrate level >1.2 mmol/L and blood glucose level <3.0 mmol/L7,55. All sheep were euthanized and samples were collected. The feed formula and nutrient composition were provided in Supplementary Table 4. Mice Female BALB/c mice aged 7 to 8 weeks were obtained from Beijing SiPeiFu Biotechnology Co., Ltd. and housed under specific pathogen free conditions with a 12 h light and 12 h dark schedule at 20 to 22 °C and 60% ± 10% humidity. In Fig. 1, colitis was induced by administering DSS (MP Biomedicals, USA) at a final concentration of 3% (w/v) in the drinking water. In addition, a 50% CR regimen for pregnant mice was established based on a previously published protocol56. Dietary restriction during pregnancy was implemented by precisely controlling both feeding time and food quantity. Mice in the CR group had ad libitum access to water and were provided with a defined amount of food once daily at approximately 15:00. Daily food intake for CR mice was adjusted according to gestational stage: 4.21 g/day at 7.5–9.5-day, 4.59 g/day at 10.5–12.5-day, 6.04 g/day at 13.5–15.5-day, and 6.65 g/day at 16.5–18.5-day. These intake levels were estimated based on historical feeding records from CR mice. The daily ration was placed directly on the cage floor. During the experimental period, mice in the CH were administered choline chloride (Cat. HY-B1337, MCE, China) at a physiological dose (20 mg/kg) by oral gavage. Mice in the FMT were given an oral gavage 200 μL/d of bacterial fluid from the colonic content of sheep in the RPC group. The bacterial fluid was prepared by dissolving 5 g colonic content into 50 mL saline, filtering through double gauze, and ensuring that the microbial concentration was greater than 1 × 108 CFU/200 μL. Mice in the CB were given 200 μL/d C. bacterium (1 × 108 CFU/200 μL) by oral gavage. Mice in the DCA were administered with 100 μL/d DCA (Cat. HY-N0593A, MCE, China) at a physiological dose (20 mg/kg) by enema. For the mice experiments, the dosages of choline chloride and DCA were carefully selected to accurately reflect physiological concentrations within the intestinal tract50,57. Finally, all the mice were anesthetized and euthanized after the experiment. Bacteria C. bacterium (NBRC 108820) was obtained from the Biological Resource Center, NITE (NBRC), which were previously isolated from healthy individual. The strain was routinely cultured in liquid medium at 37 °C in an HYQX-I anaerobic incubator (Yuejin, China) with a gas mixture of 5% hydrogen, 10% carbon dioxide, and 85% nitrogen. For C. bacterium culture assays, the culture medium was additionally supplemented with 3 mM choline chloride. Cell lines The human colon epithelial cell line Caco-2 (RRID: CVCL_0025), purchased from the ATCC, was cultured in Dulbecco’s modified Eagle’s medium (Gibco, USA) containing 20% fetal bovine serum (Gibco, USA) and 1% penicillin-streptomycin (Cat. C0222, Beyotime Biotechnology, China). The cells were cultured at 37 °C in a constant temperature incubator and the CO2 concentration was maintained at 5%. After 48 h of culture, Caco-2 cells were co-treated with DCA at varying concentrations (10, 25, 50, 100, and 200 μM) and TNF-α (10 ng/mL) for 12 h. DNA extraction and preparation Genomic DNA in colonic content samples of sheep was extracted using a fecal genomic DNA kit (Cat. 51604, QIAGEN, Germany). DNA integrity was analyzed using 1% agarose gel electrophoresis. The quality and concentration of each DNA sample was determined on a Nanodrop spectrophotometer (Thermo Fisher, Wisconsin, USA). Metagenomic sequencing Twenty-four sheep colonic content DNA samples (n = 6) were randomly fragmented by ultrasonication, and constructed into libraries for paired-end sequencing on an MGIseq 2000 platform (BGI Genomics, China). Trimmomatic 0.38 and Bowtie 2 were then used to remove adapters, low-quality reads, and host contamination from the raw sequencing data. The filtered valid sequences were assembled using the splicing software megahit. The contigs in the assembly results were used to predict genes using the MetaGeneMark software, and sequences with a gene length less than 100 nt were filtered out. Gene predictions from all samples were pooled, and redundant sequences were clustered with CD HIT to generate a non-redundant gene catalog. Clustering was performed using the parameters 95% identity and 90% coverage. Clean reads from each sample were mapped to the non-redundant gene catalog using Bowtie2. Alpha diversity analysis was performed using the R package “vegan” and PLS-DA was plotted using SIMCA 14.1. Correlation networks at the genus level were visualized using Gephi 0.10.1. The p-adjust function in R software was utilized to correct metagenomic p values via the Benjamini-Hochberg method, thereby achieving false discovery rate (FDR) correction. RNA-sequencing Total RNA was extracted from sheep colonic epithelium (n = 5) using the Trizol reagent. RNA concentration, purity, and integrity were assessed prior to library preparation. cDNA libraries were prepared and sequenced on an Illumina HiSeq 2500. Raw reads were processed with fastp to remove low quality sequences and adapters, and the retained reads were mapped to the sheep reference genome Oar v4.0 using HISAT2. Gene level differential expression was analyzed with DESeq2, with significance defined as an absolute log2 fold change greater than 1 and an adjusted p value of 0.05 or less. Subsequently, gene set enrichment analysis (GSEA) was performed using the GSEA software with default parameters, based on the KEGG pathway database. Non-targeted metabolomics Twelve sheep colonic content samples were randomly selected from the UN and RPC group (n = 6) for non-targeted metabolome analysis using UHPLC-MS. Colonic contents were extracted with an 80% aqueous methanol solution, and the supernatants were injected into a Hypesil Gold column (100 × 2.1 mm, 1.9 μm) and eluted with a linear gradient using the method reported by Dai et al.58. Raw data generated by UHPLC-MS/MS were processed using Compound Discoverer 3.1 to identify metabolites via the comparation of mzCloud, mzVault, and MassList. Differential metabolites were defined by an FDR below 0.05 together with VIP greater than 1 and |log2FC | >1. Pathway enrichment for these metabolites was conducted with MetaboAnalyst using KEGG annotations. PCA plot of the total metabolites in colonic content was made using SIMCA 14.1. Targeted bile acid testing Sheep colonic content samples were randomly selected (n = 5) and extracted with methanol/acetonitrile (v/v = 2:8). The sample extracts were analyzed using an LC-MS/MS system. Chromatographic separation was carried out on a Waters ACQUITY UPLC HSS T3 C18 column (100 × 2.1 mm, 1.8 µm) maintained at 40 °C with a flow rate of 0.35 mL per minute. Data were acquired on a triple quadrupole linear ion trap mass spectrometer using gradient elution in negative ion mode. Bile acids were quantified by scheduled multiple reaction monitoring. Further details can be found in the reference reported by Zhao et al.59. Instrument control and data collection were carried out in Analyst 1.6.3, and metabolite quantification was performed with MultiQuant 3.0.3. PLS-DA plot of the total bile acids in liver, jejunum, and colon was made using SIMCA 14.1. DAI score The severity of the disease was assessed daily using a scoring system based on weight loss, stool consistency, and degree of intestinal bleeding60. The scores of weight loss (0: none; 1: 1–5%; 2: 6–10%; 3: 11–18%; 4: >18%), stool consistency (0: normal; 1: soft but still formed; 2: soft; 3: very soft or wet; 4: watery diarrhea), and blood (0: negative ; 1: negative ; 2: positive; 3: blood traces in stool visible; 4: gross rectal bleeding) were evaluated, respectively. The DAI score was the sum of these three individual scores. Fecal occult blood in mice was detected using a commercial fecal occult blood detection kit (Cat. R21607 and R24187, Yuanye, China). HE staining and histology score The colon tissue was embedded in paraffin, sectioned, deparaffinized, and rehydrated, and finally stained with HE. All colon specimens were photographed using an Olympus IX73 (Tokyo, Japan). Histology scores were independently assessed by three pathologists according to the criteria described by Shen et al.61. PAS staining Colon tissue embedded in paraffin were sectioned to 5 μm thickness and stained with PAS for histological visualization. Blue-stained goblet cells were counted in 40 x field views under an Olympus IX73 microscope (Tokyo, Japan). Immunofluorescence staining Immunofluorescence staining of paraffin sections of colonic tissue was performed using the standard protocol. Briefly, samples were incubated with primary antibodies Claudin-1 (Cat. 13050-1-AP, Proteintech, China) or ZO-1 (Cat. 21773-1-AP, Proteintech, China) overnight at 4 °C. FITC or Cy5-conjugated secondary antibodies were loaded and incubated for 2 h at room temperature. The sections were observed using a laser scanning confocal microscope (Zeiss LSM 900, Oberkochen, Germany). The fluorescence intensity was quantitated with ImageJ software in at least eight random fields. Biochemical analysis IL-1β (sheep: Cat. CSB-E10115Sh; mouse: Cat. CSB-E08054m; human: Cat. CSB-E08053h), IL-6 (sheep: Cat. CSB-E10116Sh; mouse: Cat. CSB-E04639m; human: Cat. CSB-E04638h), and TNF-α (sheep: Cat. CSB-E13853Sh; mouse: Cat. CSB-E04741m) levels in the colon tissue were measured using ELISA kits (CUSABIO, Wuhan, China) according to the manufacturer’s instructions. BSH activity determination BSH activity was determined according to the method described by Chen et al.62. In brief, 0.5 g intestinal content was dissolved in 1 mL PBS buffer and 5 mL extraction buffer. After vortex, the bacteria were lysed using a cell ultrasonic disruptor (95 V, 18 s intervals, 5 s disruption, 60 times), and then centrifuged at 4 °C and 14,000 × g for 30 min to obtain the supernatant (crude enzyme). The protein concentration of the supernatant was determined according to the manufacturer’s instructions (Cat. P0010S, Beyotime Biotechnology, China). Enzyme reactions (200 μL total volume) were conducted at 37 °C for 20 min, containing: 10 μL crude enzyme extract (0.1 mg/mL protein), 10 μL of 5 mM TCA, and 180 μL PBS. Reactions were terminated immediately by adding 200 μL of 15% (w/v) trichloroacetic, followed by centrifugation to collect supernatants. The amino acid concentration in the supernatant was determined using a ninhydrin colorimetric method. BSH activity toward taurocolic acid was reported as the amount of amino acid released per minute per milligram of crude enzyme. CCK8 assay Caco-2 cells were plated in 96 well plates and exposed to the indicated treatments. CCK8 reagent (Cat. K1018, APExBIO, USA) was added in medium, and absorbance at 450 nm was measured to assess cell viability. Real-time quantitative PCR analysis Total RNA was isolated from colonic tissue using TRIzol reagent (Cat. ET101-01-V2, TransGen Biotech, China) following the manufacturer’s protocol. RNA concentration and purity were assessed with a NanoDrop spectrophotometer (Thermo Fisher Scientific, Wisconsin, USA). Quantitative PCR was performed on a BioRad CFX Connect system (BioRad, California, USA) using SYBR Green chemistry with Hieff qPCR SYBR Green Master Mix (Yeasen Biotechnology, Shanghai, China). Relative transcript abundance was calculated by the 2-ΔΔCT method, normalized to β-actin. Primer information is provided in Supplementary Table 5. Western blotting Protein lysates from tissues and cultured cells were quantified with a BCA assay (Cat. BL521S, Biosharp, China). An equal protein mass was resolved by SDS-PAGE and transferred to PVDF membranes. Membranes were blocked in 5% BSA and incubated with primary antibodies at 4 °C overnight, then probed with the corresponding secondary antibodies for 1 h at room temperature. The primary antibodies used include Nur77 (Cat. ab153914, Abcam, UK), p-p65 (Cat. ab76302, Abcam, UK), p65 (Cat. ab32536, Abcam, UK), and β-actin (Cat. ab8227, Abcam, UK). Protein bands were visualized using ECL and quantified by densitometric analysis using ImageJ software. Structural equation model analysis Structural equation model was constructed to evaluate the sequential regulatory cascade among choline intervention, colonic C. bacterium abundance, BSH activity, DCA levels, and host Nur77 expression. The path coefficients and their statistical significance were calculated to represent the effect sizes of direct relationships. The structural equation model analysis was conducted using the lavaan package in R. Statistical analysis Two-tailed Student’s t test (passed the Shapiro-Wilk normality test) and two-tailed Wilcoxon rank sum test (not passed the Shapiro-Wilk normality test) were used to analyzed the data between two groups. one-way ANOVA, with significant differences further evaluated used Tukey ‘s post hoc test (passed the Shapiro-Wilk normality test) and non-parametric Kruskal-Wallis test, with significant differences further evaluated used paired Wilcoxon rank sum post-test (not passed the Shapiro-Wilk normality test) were used to analyzed the data from more than two groups. The two-tailed Wilcoxon rank sum test or non-parametric Kruskal-Wallis test was used for metagenomic, RNA sequencing, untargeted metabolomic, and targeted bile acid data. IBM SPSS 25.0 (IBM Corp, Armonk, New York, USA) was used for statistical treatment. Experimental data are presented as mean ± SEM. No data were excluded from the data analysis. p < 0.05 was considered significant. Supplementary information Supplementary Information Acknowledgements We acknowledge Figdraw (www.figdraw.com) for providing the graphical elements and images used to create the figures. We also thank Shanghai MENON Company, China, for providing the rumen-protected choline product used in this study. This work was supported by the National Natural Science Foundation of China (32402767), National Key Research and Development Program of China (2022YFD1301102), Natural Science Research Project of Anhui Province (2025AHGXZK40221), Anhui Provincial Science and Technology Aid Project for Tibet, Xinjiang, and Qinghai (202526k16020002), Anhui Provincial Natural Science Foundation (2308085QC104), and AAU Introduction of High-level Talent Funds (RC392107). Author contributions W.W., Y.X., and J.C. conceived and planned the experiments. Y.X., S.M., and J.C. designed and supervised the study. W.W. and P.J. performed the experiments and analyzed the data. W.W., P.J., Y.G., H.L., and C.F. wrote the manuscript. Y.X., Z.S., S.M., and W.W. revised the manuscript. All the authors edited the manuscript and approved the final manuscript. Data availability Data of metagenomics, transcriptome, and metabolomics have been deposited at the Sequence Read Archive (SRA) database: PRJNA1195718, PRJNA1397498, or Figshare database: https://figshare.com/s/d4a569b260ebba843660. These data are publicly available as of the date of publication. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally: Weibin Wu, Peng Jiao, Yamei Gu. Contributor Information Shengyong Mao, Email: maoshengyong@njau.edu.cn. Jianbo Cheng, Email: chengjianbofcy@163.com. Yanfeng Xue, Email: xueyanfeng1990@163.com. Supplementary information The online version contains supplementary material available at 10.1038/s41522-026-01027-2. References Associated Data Supplementary Materials Supplementary Information Data Availability Statement Data of metagenomics, transcriptome, and metabolomics have been deposited at the Sequence Read Archive (SRA) database: PRJNA1195718, PRJNA1397498, or Figshare database: https://figshare.com/s/d4a569b260ebba843660. These data are publicly available as of the date of publication.